Ordinary Share Capital Veränderung Datum
AbbVie USD 18M 0 2023-09
Acadia Pharmaceuticals USD 16K 0 2023-12
ALKERMES USD 1.72M 2K 2023-09
Amgen USD 32.75B 152M 2023-09
Bayer EUR 2.52B 0 2023-09
Biogen USD 100K 0 2023-12
BioMarin Pharmaceutical USD 189K 1000 2023-12
Bluebird Bio USD 1.07M 6K 2023-09
Bristol-Myers Squibb USD 292M 0 2023-09
Eli Lilly USD 593.6M 0 2023-09
Esperion Therapeutics USD 112K 11K 2023-09
Gilead Sciences USD 1000K 0 2023-09
Incyte USD 224K 0 2023-12
Intra Cellular Therapies USD 10K 0 2023-12
Marinus Pharmaceuticals USD 55K 4K 2023-09
Merck USD 1.79B 0 2023-09
Moderna USD 38.2K 100 2023-12
Neurocrine Biosciences USD 100K 0 2023-09
Novartis USD 825M 17M 2023-09
Pfizer USD 478M 0 2023-09
PTC Therapeutics USD 75K 0 2023-12
Regeneron Pharmaceuticals USD 102K 0 2023-09
Sarepta Therapeutics USD 9K 0 2023-09
Ultragenyx Pharmaceutical USD 72K 1000 2023-09
United Therapeutics USD 700K 0 2023-12
Vertex Pharmaceuticals USD 2.6M 0 2023-09



Biogen Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.